RoslinCT continues its growth plans by expanding its operations at Edinburgh Technopole

Released: Wednesday 8th June 2022

Edinburgh, UK, 08 June 2022 – RoslinCT - a cell and gene therapy/ATMP CDMO, developing life-changing cell and gene therapies in Edinburgh’s BioQuarter– signs lease for 1,453 sqm additional space at Charles Darwin House at the Edinburgh Technopole.

For full details please click here.

View all News